Company Name: |
TargetMol Chemicals Inc.
|
Tel: |
15002134094 |
Email: |
marketing@targetmol.cn |
Products Intro: |
Product Name:Quinine hydrobromide CAS:549-49-5 Package:25mg/RMB 14900;50mg/RMB 19420;100mg/RMB 24625
|
QUININE HYDROBROMIDE manufacturers
- Quinine hydrobromide
-
- $2140.00 / 25mg
-
2025-04-30
- CAS:549-49-5
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| QUININE HYDROBROMIDE Basic information |
Product Name: | QUININE HYDROBROMIDE | Synonyms: | QUININE HYDROBROMIDE;6’-methoxy-,monohydrobromide,(8-alpha,9r)-cinchonan-9-o;bromoquinine;chininhydrobromid;quinine,monohydrobromide;Quinini;(5-ethenyl-1-azabicyclo[2.2.2]octan-7-yl)-(6-methoxyquinolin-4-yl)methanol hydrobromide;(6-methoxy-4-quinolyl)-(5-vinylquinuclidin-2-yl)methanol hydrobromide | CAS: | 549-49-5 | MF: | C20H25BrN2O2 | MW: | 405.33 | EINECS: | 208-967-2 | Product Categories: | | Mol File: | 549-49-5.mol |  |
| QUININE HYDROBROMIDE Chemical Properties |
| QUININE HYDROBROMIDE Usage And Synthesis |
Chemical Properties | yellow prisms | Uses | Quinidine hydrobromide is an antiarrhythmic agent. Quinidine is a potent, orally active, selective cytochrome P450db inhibitor. Quinidine hydrobromide is also a K+ channel blocker with an IC50 of 19.9 μM. Quinidine hydrobromide can be used for malaria research[1][2][3]. | in vivo | Quinidine hydrobromide is rapidly absorbed, with peak plasma concentrations 60-90 min after an oral dose. Other salts (gluconate, polygalacturonate) are more slowly absorbed, with lower peak concentrations[2].
Quinidine hydrobromide is approximately 70-90 % bound to plasma proteins. It undergoes hepatic oxidative metabolism to form an N-oxide, a 3-hydroxy form, an O-demethyl form and 2'-quinidinone[2].
Quinidine hydrobromide inhibits metabolism of amphetamine in rats. Quinidine hydrobromide pretreatment results in a significant decrease in the excretion of p-hydroxyamphetamine at 24 and 48 h to 7.2 and 24.1% of the vehicle-control levels, respectively, accompanied by a significant increase in amphetamine excretion between 24 and 48 h to 542% of the control[3]. | References | [1] Kehl SJ, et al. Quinidine-induced inhibition of the fast transient outward K+ current in rat melanotrophs. Br J Pharmacol. 1991 Jul;103(3):1807-13. DOI:10.1111/j.1476-5381.1991.tb09867.x [2] Roden DM, et al. Class I antiarrhythmic agents: quinidine, procainamide and N-acetylprocainamide, disopyramide. DOI:10.1016/0163-7258(83)90012-8 |
| QUININE HYDROBROMIDE Preparation Products And Raw materials |
|